Search

everythinglearnresearchcommunity

for

Search:↓

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Tirzepatide may improve hair loss by reducing insulin resistance.

Topical gabapentin was safe and effective for treating scalp symptoms and promoting hair regrowth in cicatricial alopecias.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Epidermal growth factor helps hair regrow after chemotherapy.

Blocking CISD1 reduces hearing loss from cisplatin in mice.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

A synthetic octapeptide may help promote hair growth and counteract hair loss.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Gefitinib can cause scalp skin issues and permanent hair loss.

A man developed alopecia areata after starting cancer treatment with vandetanib.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

CPGel hydrogel heals diabetic wounds effectively in 21 days.

Both hair tonic and gel with Angiopteris evecta extract effectively stimulate hair growth.

Etoposide makes radiation therapy more effective against tumors without major side effects.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Eucalyptus and Tween 80 most effectively increase cetirizine skin absorption.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Baricitinib may effectively treat lichen planopilaris.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

Celtis choseniana may help treat hair loss by reducing androgen effects and boosting hair growth signals.

Ruxolitinib can help regrow hair in severe alopecia areata.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Promising cancer treatments were found, but the manufacturer closed.